Latest Brain tumor Stories

Hair transplant will be broadcast live on TheBaldTruth.com on July 30, 2012 at 11:00 a.m. PST. Walnut Creek, CA (PRWEB) July 27, 2012 Bay Area hair restoration surgeon, Sara Wasserbauer, M.D., will perform a pro bono hair transplant on a young man who battled a brain tumor eight years ago. The surgery will be broadcast live on TheBaldTruth.com on July 30, 2012 at 11:00 a.m. PST. Carlos Cabrera was just 18 years old when he was diagnosed with a rare brain tumor called ganlioglioma. He...

Researchers at Columbia University Medical Center (CUMC) have discovered that some cases of glioblastoma, the most common and aggressive form of primary brain cancer, are caused by the fusion of two adjacent genes. The study also found that drugs that target the protein produced by this genetic aberration can dramatically slow the growth of glioblastomas in mice. The findings were published today in the online edition of the journal Science. "Our findings are doubly important," said study...

Performing surgery to remove a brain tumor requires surgeons to walk a very fine line. If they leave tumor tissue behind, the tumor is likely to regrow; if they cut out too much normal tissue, they could cause permanent brain damage. "Primary brain tumors look just like brain tissue," says Keith Paulsen, PhD, a professor of biomedical engineering at Thayer School of Engineering and a member of the Cancer Imaging and Radiobiology Research Program at Norris Cotton Cancer Center. "But if...

Northwestern Brain Tumor Institute participates in national glioblastoma clinical trial CHICAGO, July 24, 2012 /PRNewswire-USNewswire/ -- Researchers at Northwestern Brain Tumor Institute (NBTI) are seeking to understand if a vaccine made from a patient's own blood cells may slow the growth of a type of brain tumor. The trial is studying the vaccine's effect on glioblastoma multiformes (GBM), the most common and aggressive type of primary brain tumor. The trial is an example of a...

MDC and Charite researchers decipher the mechanism of action Neural precursor cells (NPC) in the young brain suppress certain brain tumors such as high-grade gliomas, especially glioblastoma (GBM), which are among the most common and most aggressive tumors. Now researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch and Charité – Universitätsmedizin Berlin have deciphered the underlying mechanism of action with which neural precursor cells protect the young...

redOrbit Staff & Wire Reports - Your Universe Online Researchers from several prominent medical institutions claim that they have identified several genetic mutations responsible for medulloblastoma, the most common malignant type of childhood brain tumor. There are four recognized subtypes of medulloblastomas, which occur in the part of the brain responsible for controlling balance and other complex motor functions (the cerebellum), Boston Children's Hospital researchers explained...

Findings could enable individualized treatment for patients with medulloblastoma BOSTON, July 22, 2012 /PRNewswire-USNewswire/ -- Researchers at Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) and several collaborating institutions have linked mutations in specific genes to each of the four recognized subtypes of medulloblastoma, the most common malignant brain tumor of children. The discovery, reported July in the journal Nature, provides doctors with potential biomarkers...

High risk and better outcome for glioma wrapped up in rare gene variant Researchers at Moffitt Cancer Center working with colleagues at three other institutions have validated a link between a rare genetic variant and the risk of glioma, the most common and lethal type of brain tumor. The validation study also uncovered an association between the same rare genetic variant and improved rates of survival for patients with glioma. The study, the first to confirm a rare susceptibility...

Death of first wife makes things more personal for scientist working to improve quality of life of brain tumor patients receiving radiation therapy WINSTON-SALEM, N.C., June 26, 2012 /PRNewswire-USNewswire/ -- The following is being released by Wake Forest Baptist Medical Center HealthWire: (Logo: http://photos.prnewswire.com/prnh/20111114/DC06171LOGO) Mike Robbins knows all too well the likely outcome when patients are diagnosed with brain tumors that are "high grade." The median...

Multiple sclerosis (MS) patients appear to have a lower cancer risk, according to a new study led by researchers at the University of British Columbia and Vancouver Coastal Health. The study, published in the current issue of the journal Brain, is the first to investigate overall cancer risk in MS patients in North America. "Because the immune system plays important roles in both cancer and MS, we wanted to know whether the risk of cancer is different for people with MS," says Elaine...